Egg phospholipids

DB14233ApprovedWithdrawn

Egg phospholipids is a compound used as a calorie source in parenteral nutrition. Egg phospholipids are primarily a mixture of naturally occurring phospholipids which are isolated from the egg yolk.

Primary indication
For use as a source of calories for patients requiring parenteral nutrition.Curator reviewed · 1 structured indication
First approval
Canada, 1999 · United States, 1984
Also known as
Egg lecithin · Egg lecithin component of endolipide · Egg oil lecithin · Egg oil phospholipids · Egg phosphatides

Resolves to

Compound
UNII1Z74184RGVCAS93685-90-6
Clinical / RWD
RxNorm349762

What you can answer from here — as of March 06, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
12ContraindicationsEach with its own population and attribute set
Sign in
25Marketed productsAcross 5 countries and 9 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Egg phospholipids, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In